Related Experiment Video

Updated: Mar 31, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Global gene expression profiling data analysis reveals key gene families and biological processes inhibited by

Kirti K Kulkarni1, Kiran Gopinath Bankar1, Rohit Nandan Shukla1

  • 1Genome Informatics Research Group, Bionivid Technology Pvt Ltd., Bangalore 560043, India.

Genomics Data
|October 21, 2015
PubMed

Insights

Mithramycin, an anticancer drug, was studied for its effect on sarcoma. Researchers found it primarily represses key cellular processes and gene families, offering potential for sarcoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Mithramycin is a known anticancer drug.
  • Sarcoma is a cancer originating from mesenchymal cells.
  • Understanding Mithramycin's role in sarcoma progression is crucial despite its lower incidence.

Purpose of the Study:

  • To analyze global gene expression profile changes induced by Mithramycin in sarcoma.
  • To elucidate the molecular mechanisms of Mithramycin's action in sarcoma.

Main Methods:

  • Whole genome gene expression profiling using microarray data.
  • Analysis of gene expression changes in two distinct sarcoma cell lines treated with Mithramycin.

Main Results:

  • Mithramycin induces global repression of key cellular processes.
  • Affected gene families include phosphoproteins, kinases, and transcription regulators.
  • Processes like alternative splicing, chromatin assembly, and cytoskeleton organization are repressed.

Conclusions:

  • Mithramycin's primary anticancer action in sarcoma involves broad repression of essential cellular functions.
  • This global repression impacts multiple gene families and biological pathways.
  • Findings provide insights into Mithramycin's therapeutic potential for sarcoma.
Keywords:
Global gene expressionMicroarrayMithramycinSarcoma

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.9K
MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

382

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K